Literature DB >> 20937336

Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa.

Kazuma Ogiso1, Akihiro Asakawa, Haruka Amitani, Toshihiro Nakahara, Miharu Ushikai, Izumi Haruta, Ken-Ichiro Koyama, Marie Amitani, Toshiro Harada, Daisuke Yasuhara, Akio Inui.   

Abstract

Restricting-type anorexia nervosa (AN-R) is characterized by chronic food restriction and severe emaciation due to various cognitive biases such as a distorted self-image. In spite of several treatments, AN-R continues to be a refractory disease because of its unknown pathogenesis. Although previous studies have shown that changes in feeding regulatory peptides such as ghrelin are involved in anorexia, few reports have described the relationship between AN-R and nesfatin-1, a recently identified satiety peptide. Therefore, we examined the plasma nesfatin-1 levels in AN-R patients to determine its role in AN-R. A total of 15 women participated in the study; 7 patients with AN-R and 8 age-matched healthy controls (average BMI, 13.02 ± 0.30 vs. 21.57 ± 0.48, respectively). Our results showed that plasma nesfatin-1 levels were significantly lower in AN-R group than in control group (6.23 ± 0.70 ng/ml vs. 8.91 ± 0.85 ng/ml, respectively, P<0.05). Plasma acyl ghrelin and des-acyl ghrelin levels were significantly higher in AN-R group than in control group (acyl ghrelin: 62.4 ± 10.15 fmol/ml vs. 27.20 ± 5.60 fmol/ml, P<0.01 and des-acyl ghrelin: 300.17 ± 55.95 fmol/ml vs. 107.34 ± 40.63 fmol/ml, P<0.05). Although AN-R is associated with emaciation for a prolonged period, our result suggested that nesfatin-1 levels may be regulated by nutrition status and response to starvation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937336     DOI: 10.1016/j.peptides.2010.10.004

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  24 in total

Review 1.  Regulatory Peptide Nesfatin-1 and its Relationship with Metabolic Syndrome.

Authors:  Tuba Tekin; Betul Cicek; Nurefsan Konyaligil
Journal:  Eurasian J Med       Date:  2019-08-19

Review 2.  Minireview: nesfatin-1--an emerging new player in the brain-gut, endocrine, and metabolic axis.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

3.  mTOR-dependent modulation of gastric nesfatin-1/NUCB2.

Authors:  Ziru Li; Geyang Xu; Yin Li; Jing Zhao; Michael W Mulholland; Weizhen Zhang
Journal:  Cell Physiol Biochem       Date:  2012-04-03

4.  Lipopolysaccharide increases gastric and circulating NUCB2/nesfatin-1 concentrations in rats.

Authors:  Andreas Stengel; Miriam Goebel-Stengel; Janusz Jawien; Peter Kobelt; Yvette Taché; Nils W G Lambrecht
Journal:  Peptides       Date:  2011-07-18       Impact factor: 3.750

5.  Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis.

Authors:  A Stengel; Y Taché
Journal:  Horm Metab Res       Date:  2013-09-18       Impact factor: 2.936

Review 6.  Multi-functional peptide hormone NUCB2/nesfatin-1.

Authors:  Suleyman Aydin
Journal:  Endocrine       Date:  2013-03-23       Impact factor: 3.633

7.  Gastric peptides and their regulation of hunger and satiety.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Gastroenterol Rep       Date:  2012-12

Review 8.  The role of nesfatin-1 in the regulation of food intake and body weight: recent developments and future endeavors.

Authors:  A Stengel; M Mori; Y Taché
Journal:  Obes Rev       Date:  2013-08-27       Impact factor: 9.213

9.  Expression of gastrointestinal nesfatin-1 and gastric emptying in ventromedial hypothalamic nucleus- and ventrolateral hypothalamic nucleus-lesioned rats.

Authors:  Zi-Bin Tian; Run-Jun Deng; Gui-Rong Sun; Liang-Zhou Wei; Xin-Juan Kong; Xue-Li Ding; Xue Jing; Cui-Ping Zhang; Yin-Lin Ge
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 10.  Nesfatin-1: a new energy-regulating peptide with pleiotropic functions. Implications at cardiovascular level.

Authors:  Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; José Ramón González-Juanatey; Francisca Lago
Journal:  Endocrine       Date:  2015-12-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.